Back to Agenda
Session1: Rare Disease
Session Chair(s)
Toshihiko Doi, MD, PHD
Deputy Director / Chief, Experimental Therapeutics, National Cancer Center Hospital East, Japan
Noboru Yamamoto, MD, PHD
Deputy Director, Department of Experimental Therapeutics, National Cancer Center Hospital, Japan
Speaker(s)
George D. Demetri, MD
Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute, Inc., United States
Lessons from Rare Cancers to Accelerate Therapeutic Development Globally
Kenichi Nakamura, MD, PHD, MBA
Chief, Department of International Clinical Development, National Cancer Center Hospital, Japan
Treatment Development for Rare Cancers in Japan
Morihiko Hayashi, DVM
Clinical Development, Clinical Science & Strategy, Chugai Pharmaceutical Co., Ltd., Japan
Sakigake of Cancer Genomic Medicine ~ Entrectinib ~
Have an account?